NASDAQ: APLTApplied Therapeutics Inc Stock Ownership - Who owns Applied Therapeutics?
Insider buying vs selling
Have Applied Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Constantine Chinoporos | Chief Operating Officer and Chief Business Officer | 2025-03-04 | 447 | $0.44 | $196.68Sell |
| Leslie D. Funtleyder | Interim Chief Executive Officer and Chief Financial Officer | 2025-03-04 | 14,502 | $0.44 | $6.38kSell |
| Riccardo Perfetti | Chief Medical Officer | 2025-03-04 | 10,366 | $0.44 | $4.56kSell |
| Constantine Chinoporos | Chief Operating Officer and Chief Business Officer | 2025-02-06 | 28,117 | $0.61 | $17.15kSell |
| Leslie D. Funtleyder | Interim Chief Executive Officer and Chief Financial Officer | 2025-02-06 | 22,950 | $0.61 | $14.00kSell |
| Riccardo Perfetti | Chief Medical Officer | 2025-02-06 | 86,078 | $0.61 | $52.51kSell |
APLT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when APLT insiders and whales buy or sell their stock.
APLT Shareholders
What type of owners hold Applied Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| T Rowe Price Investment Management Inc | 12.97% | 18,683,990 | $21.49M | Institution |
| Vestal Point Capital LP | 7.99% | 11,500,000 | $13.23M | Institution |
| Propel Bio Management LLC | 7.84% | 11,285,420 | $12.98M | Institution |
| Knoll Capital Management LLC | 5.42% | 7,799,687 | $8.97M | Institution |
| Shoshana Shendelman | 4.20% | 6,049,953 | $6.96M | Insider |
| Blackrock Inc | 3.62% | 5,219,686 | $6.00M | Institution |
| Vanguard Group Inc | 3.29% | 4,734,013 | $5.44M | Institution |
| Simplify Asset Management Inc | 3.12% | 4,487,505 | $5.16M | Institution |
| Pathstone Holdings LLC | 1.84% | 2,643,540 | $3.04M | Institution |
| Tang Capital Management LLC | 1.69% | 2,428,169 | $2.79M | Institution |
APLT vs Biotech Stocks
Applied Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.